These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis. Loeb JA Neurology; 2007 May; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567 [TBL] [Abstract][Full Text] [Related]
3. Glutamate inhibition in MS: the neuroprotective properties of riluzole. Killestein J; Kalkers NF; Polman CH J Neurol Sci; 2005 Jun; 233(1-2):113-5. PubMed ID: 15949499 [TBL] [Abstract][Full Text] [Related]
4. Can clinical outcomes be used to detect neuroprotection in multiple sclerosis? Khan O Neurology; 2007 May; 68(22 Suppl 3):S64-71; discussion S91-6. PubMed ID: 17548572 [TBL] [Abstract][Full Text] [Related]
6. Overcoming failure to repair demyelination in EAE: an important step towards neuroprotection in multiple sclerosis. Gold R J Neuroimmunol; 2005 Dec; 170(1-2):1-2. PubMed ID: 16298433 [No Abstract] [Full Text] [Related]
7. Advancement of therapies for neuroprotection in multiple sclerosis. Lo A Expert Rev Neurother; 2008 Sep; 8(9):1355-66. PubMed ID: 18759548 [TBL] [Abstract][Full Text] [Related]
8. Toward the development of rational therapies in multiple sclerosis: what is on the horizon? Hemmer B; Hartung HP Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020 [TBL] [Abstract][Full Text] [Related]
9. Linkage between immunomodulation, neuroprotection and neurogenesis. Aharoni R; Arnon R Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319 [TBL] [Abstract][Full Text] [Related]
10. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis. Mirowska-Guzel D Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotection: extrapolating from neurologic diseases to the eye. Danesh-Meyer HV; Levin LA Am J Ophthalmol; 2009 Aug; 148(2):186-191.e2. PubMed ID: 19464671 [TBL] [Abstract][Full Text] [Related]
12. Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment. Rostásy KM Neuropediatrics; 2005 Aug; 36(4):230-9. PubMed ID: 16138246 [TBL] [Abstract][Full Text] [Related]
13. [The repair process in an experimental wound under the effect of various hormones]. Bukhonova AI Arkh Patol; 1965; 27(8):61-4. PubMed ID: 5869687 [No Abstract] [Full Text] [Related]
14. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis. Filippi M; Agosta F Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674 [TBL] [Abstract][Full Text] [Related]
15. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment. Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotection and neuroregeneration in multiple sclerosis. Stangel M J Neurol; 2008 Dec; 255 Suppl 6():77-81. PubMed ID: 19300964 [TBL] [Abstract][Full Text] [Related]
17. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Sayeed I; Stein DG Prog Brain Res; 2009; 175():219-37. PubMed ID: 19660659 [TBL] [Abstract][Full Text] [Related]
18. Opioids modulate post-ischemic progression in a rat model of stroke. Kao TK; Ou YC; Liao SL; Chen WY; Wang CC; Chen SY; Chiang AN; Chen CJ Neurochem Int; 2008 May; 52(6):1256-65. PubMed ID: 18294735 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status. Waxman SG Nat Clin Pract Neurol; 2008 Mar; 4(3):159-69. PubMed ID: 18227822 [TBL] [Abstract][Full Text] [Related]